| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022295724 |
| P356 | DOI | 10.1186/1471-2407-9-116 |
| P932 | PMC publication ID | 2678274 |
| P698 | PubMed publication ID | 19379520 |
| P5875 | ResearchGate publication ID | 24310405 |
| P50 | author | Kevin Dew | Q55345426 |
| Sarah Hill | Q57074578 | ||
| Tony Blakely | Q57449785 | ||
| Elizabeth Dennett | Q114412323 | ||
| Diana Sarfati | Q47236709 | ||
| Bridget Robson | Q108463881 | ||
| Gordon Purdie | Q108596008 | ||
| Donna Cormack | Q90871593 | ||
| P2860 | cites work | Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors | Q50150564 |
| NZDep91: A New Zealand index of deprivation. | Q50847843 | ||
| Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. | Q50884747 | ||
| Multimorbidity and survival in older persons with colorectal cancer. | Q51771910 | ||
| Age and clinical decision making in oncology patients. | Q52881719 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| In search of the perfect comorbidity measure for use with administrative claims data: does it exist? | Q31049563 | ||
| Comorbidity measures for use with administrative data | Q32144770 | ||
| Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity | Q33302869 | ||
| Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older | Q34141839 | ||
| How to measure comorbidity. a critical review of available methods | Q34194168 | ||
| Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? | Q34546887 | ||
| A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). | Q35689334 | ||
| Prognostic importance of comorbidity in a hospital-based cancer registry | Q35783153 | ||
| Differential prognostic impact of comorbidity | Q35850854 | ||
| Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites | Q36144957 | ||
| Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 | Q36610425 | ||
| A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index | Q36614935 | ||
| Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients | Q36694327 | ||
| Using administrative data to describe casemix: a comparison with the medical record | Q36701884 | ||
| Prevalence of co-morbidity in newly diagnosed patients with cancer: a population-based study | Q41756864 | ||
| A multipurpose comorbidity scoring system performed better than the Charlson index | Q43464895 | ||
| Age and adjuvant chemotherapy use after surgery for stage III colon cancer | Q43534600 | ||
| A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients | Q43763447 | ||
| Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer | Q43902636 | ||
| Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer | Q44155885 | ||
| Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer | Q44217665 | ||
| In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. | Q44916339 | ||
| Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer | Q46614231 | ||
| Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer | Q57895974 | ||
| Impact of comorbidity on lung cancer survival | Q57895993 | ||
| NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer | Q68536918 | ||
| The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03 | Q70505757 | ||
| Cancer treatment and age: patient perspectives | Q70508103 | ||
| The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer | Q70799897 | ||
| Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989 | Q72295054 | ||
| The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection | Q74446316 | ||
| Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients | Q77517173 | ||
| Patient age and cancer treatment decisions. Patient and physician views | Q77774637 | ||
| Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer | Q79219078 | ||
| Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study | Q79310426 | ||
| A user's guide to selecting a comorbidity index for clinical research | Q79861653 | ||
| Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer | Q80198681 | ||
| The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer | Q80353279 | ||
| Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer | Q81547935 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| chemotherapy | Q974135 | ||
| comorbidity | Q1414874 | ||
| P304 | page(s) | 116 | |
| P577 | publication date | 2009-04-20 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study | |
| P478 | volume | 9 |
| Q34517306 | A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes |
| Q30625567 | Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans. |
| Q48265163 | Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study |
| Q36151471 | Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation |
| Q89839031 | Antineoplastic drugs prescription during visits by adult cancer patients with comorbidities: findings from the 2010-2016 National Ambulatory Medical Care Survey |
| Q30980384 | Assessing measures of comorbidity and functional status for risk adjustment to compare hospital performance for colorectal cancer surgery: a retrospective data-linkage study. |
| Q47627901 | Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region |
| Q39244502 | Colorectal cancer among Indigenous and non-Indigenous people in Queensland, Australia: Toward survival equality |
| Q41060679 | Colorectal cancer patients: what do they die of? |
| Q35789138 | Comorbid chronic diseases and their associations with quality of life among gynecological cancer survivors |
| Q37288177 | Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study |
| Q92971998 | Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers |
| Q38858796 | Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study |
| Q27690236 | Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review |
| Q45977458 | Deprivation and access to treatment for colorectal cancer in Southeast Scotland 2003-2009. |
| Q55049143 | Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer. |
| Q34656583 | Diabetes mellitus and colorectal cancer prognosis: a meta-analysis |
| Q43682843 | Differences in survival for patients with metastatic colorectal cancer by lines of treatment received and stage at original diagnosis |
| Q37214361 | Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study |
| Q44462057 | Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal? |
| Q46461932 | Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients |
| Q30719268 | Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival |
| Q92777679 | Improving management of comorbidity in patients with colorectal cancer using comprehensive medical assessment: a pilot study |
| Q35944238 | Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10 |
| Q38237484 | Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage |
| Q51525751 | Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. |
| Q35805877 | Optimal management of colorectal liver metastases in older patients: a decision analysis |
| Q37646576 | Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014). |
| Q31171263 | Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities |
| Q34467975 | Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients. |
| Q89679100 | The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007-2017 |
| Q36895084 | The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients |
| Q26764935 | The impact of comorbidity on cancer and its treatment |
| Q37288186 | The impact of comorbidity on cancer survival: a review |
| Q39265974 | The impact of comorbidity on the relationship between life stress and health-related quality of life for Chinese- and Korean-American breast cancer survivors |
| Q90402388 | The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria |
| Q36618847 | The post-treatment experience of cancer survivors with pre-existing cardiopulmonary disease |
| Q57192928 | The relationship between comorbidity medication adherence and health related quality of life among patients with cancer |
| Q36808836 | Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older. |
| Q90354197 | Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses |
| Q47141257 | Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries |
Search more.